Tiger Brokers

异动解读 | Illumina盘前大涨6.16%，第三季度业绩超预期并上调全年展望

异动解读
Oct 31

基因测序公司Illumina（ILMN）周五盘前股价大涨6.16%，延续了前一天夜间交易中的强劲涨势。这波涨势主要源于公司发布的第三季度财报超出市场预期，以及上调全年业绩展望。

根据Illumina公布的财报，公司第三季度调整后每股收益达1.34美元，显著超过分析师预期的1.17美元。季度收入为10.8亿美元，略高于分析师预期的10.7亿美元，与去年同期持平。公司首席执行官Jacob Thaysen表示，这一优异表现得益于其最大市场细分临床业务收入的加速增长。此外，公司在本季度将非通用会计准则营业利润率提高至24.5%，高于去年同期的22.6%，同时产生了2.84亿美元的经营现金流和2.53亿美元的自由现金流。

在强劲业绩的支撑下，Illumina上调了2025财年全年指引。公司现预计固定汇率总收入下降幅度收窄至0.5%至1.5%，中国以外地区的收入增长预计为0.5%至1.5%。更值得注意的是，Illumina将全年调整后每股收益指引上调至4.65-4.75美元，同时将非通用会计准则营业利润率预测提高至22.75%-23%。这些积极的财务指标无疑增强了投资者对公司未来发展的信心，推动了股价的大幅上涨。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10